- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00570362
Systemic Glutathione Level in Normal Tension Glaucoma
Evaluation of Systemic Glutathione Level in Patients With Normal Tension Glaucoma
Study Overview
Status
Conditions
Detailed Description
Normal tension glaucoma is one of the most common cause of primary open angle glaucoma in Korea. Even though, we still do not know what the cause is. Only IOP-lowering drugs are the currently available therapeutic method. Glutathione is one of the mostly high concentrated intracellular antioxidants. We find apoptosis of neuronal cell in the mouse retina by systemic depletion of glutathione using buthionine sulfoximine. Glutathione is also known to be reduced in primary open angle glaucoma with high IOP. So we are planning to evaluate systemic glutathione level in normal tension glaucoma.
Blood samples will be obtained by venipuncture to the antecubital vein of normal tension glaucoma patients and age-matched normal controls. Five milliliters of blood will be collected in EDTA-treated tubes (to prevent oxidation). Thirty microliters of blood will be then transferred into centrifuge tubes, and will be added 33.3 microliter of 5-sulfosalicylic acid (SSA), 100mg/mL within 10 minutes from the blood collection.Each sample will be then diluted with 936.7 microliter sodium phosphate buffer (pH 7.5), and the content of each tube will be mixed rapidly in a centrifuge at 13,000 rpm for 5 minutes. A portion of supernatant (150 microliter) will be then collected into clean centrifuge tubes and immediately cooled at -70°C. To each well of a 96-well plate, 150 microliter of daily buffer (3 mg NADPH into 10 mL sodium phosphate buffer), 50microliter of DTNB solution, and 25 microliter of standards or samples will be added in quadruplicate, and the plate will be incubated at 37 °C for 3 minutes.Finally, 25 microliter GSSGR will be added to the previous mixture, and the plate will be read at 410 nm using a 96-well plate reader(UV spectrophotometer).
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Seoul, Korea, Republic of, 150-713
- College of Medicine, The Catholic University of Korea, St. Mary's Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Patients were included in the normal tension glaucoma group according to the following criteria.
Inclusion Criteria (normal tension glaucoma group):
- Clinical Diagnosis of Normal Tension Glaucoma: Patients underwent diurnal IOP phasing and were diagnosed as having normal tension glaucoma(IOP always lesser than 22 mm Hg by applanation tonometry), glaucomatous optic disc cupping on fundoscopic examination, open anterior chamber angles by gonioscopy(Schaffer grade III or more), and repeatable VF defects consistent with the diagnosis of glaucoma, according to results obtained with program 24-2 of the Humphrey Field Analyzer.
- Must be able to provide intravenous blood sampling
Exclusion Criteria (normal tension glaucoma group):
- Narrow iridocorneal angles
- Any evidence of secondary open-angle glaucoma
- Any other ocular disease except cataract
- History of previous intraocular surgery including cataract
- Any other systemic disease except hypertension
The control group was composed of age-matched healthy volunteers who had neither glaucoma nor other ocular diseases such as cataract, diabetic retinopathy or age related macular degeneration. The control group did not show any glaucomatous optic disc cupping on fundoscopic examination or visual field defects with program 24-2 of the Humphrey Field Analyzer. The healthy volunteers in the control group must be able to provide intravenous blood sampling.
Exclusion criteria for both groups:
- Smoking
- History of any chronic systemic disease with presumed low glutathione levels, including autoimmune diseases, alcoholic liver disease, cancer, and diabetes mellitus.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total Glutathione Levels
Time Frame: Once in the morning.
|
Subjects were instructed to fast from midnight to 8 AM on the morning of the test.
All blood samples were obtained by a qualified registered nurse in the morning, between 8 and 10 AM.
|
Once in the morning.
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Jung-Il Moon, Professor, Department of Ophthalmology, St.Mary's Hospital, College of Medicine, The Catholic University of Korea
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Merck-001
- CMCEYE-GSH
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Normal Tension Glaucoma
-
Qlaris Bio, Inc.CompletedNormal Tension Glaucoma (NTG)United States
-
University of North Carolina, Chapel HillSensimed AGCompletedNormal-Tension GlaucomaUnited States
-
Qlaris Bio, Inc.Not yet recruitingGlaucoma | Normal Tension Glaucoma (NTG) | Low-Tension Glaucoma, Bilateral | Low-Tension Glaucoma, Unspecified EyeKorea, Republic of, Philippines
-
Technische Universität DresdenCompletedNormal Tension Glaucoma | High Tension Glaucoma
-
Helsinki University Central HospitalRecruitingNormal Tension GlaucomaFinland
-
Robert Ritch, MD, LLC.UnknownNormal Tension GlaucomaUnited States
-
pH PharmaCompletedNormal Tension GlaucomaKorea, Republic of
-
Intuor Technologies, Inc.Not yet recruitingOcular Hypertension | Glaucoma | Normal Tension GlaucomaUnited States
-
Salus UniversityNot yet recruitingNormal Tension GlaucomaUnited States
-
Merck Sharp & Dohme LLCCompleted